23 May 2013
Keywords: altus, starts, ph, iii, trial, altu-135, usa-based
Article | 14 May 2007
USA-based drugmaker Altus Pharmaceuticals says it has initiated a Phase III trial of ALTU-135, its developmental treatment for cystic fibrosis
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2007
22 May 2013
© 2013 thepharmaletter.com